Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Identification of Key Blood Molecular Markers for Immunotherapy
Identification of Key Blood Molecular Markers for Immunotherapy
Status: Archived
Stanford University School of Medicine
mi
from
Stanford, CA
Identification of Key Blood Molecular Markers for Immunotherapy
Identification of Key Blood Molecular Markers for Immunotherapy
Status: Archived
Updated: 1/1/1970
Stanford University School of Medicine
mi
from
Stanford, CA
Assessing Response to Treatment in Patients With Solid Tumors
Volumetric Analysis in the Assessment of Therapy Response by CT
Status: Archived
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Assessing Response to Treatment in Patients With Solid Tumors
Volumetric Analysis in the Assessment of Therapy Response by CT
Status: Archived
Updated: 1/1/1970
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Local Institution
mi
from
New York, NY
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Updated: 1/1/1970
Local Institution
mi
from
New York, NY
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Local Institution
mi
from
Houston, TX
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Updated: 1/1/1970
Local Institution
mi
from
Houston, TX
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer
A Phase 1 Multiple Ascending Dose Study of BMS-833923 in Subjects With Advanced or Metastatic Solid Tumors
Status: Archived
Updated: 1/1/1970
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Los Angeles, CA
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Fletcher Allen Health Care
mi
from
Burlington, VT
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Updated: 1/1/1970
Fletcher Allen Health Care
mi
from
Burlington, VT
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Pfizer Investigational Site
mi
from
Houston, TX
Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Phase 1, Open Label, Sequential Cohort, Dose Escalation Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors
Status: Archived
Updated: 1/1/1970
Pfizer Investigational Site
mi
from
Houston, TX
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
San Francisco Oncology Associates
mi
from
San Francisco, CA
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
San Francisco Oncology Associates
mi
from
San Francisco, CA
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Center for Hematology Oncology
mi
from
Boca Raton, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Center for Hematology Oncology
mi
from
Boca Raton, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Florida Cancer Specialists
mi
from
Fort Myers, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Florida Cancer Specialists
mi
from
Fort Myers, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Watson Clinic Center for Research, Inc.
mi
from
Lakeland, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Watson Clinic Center for Research, Inc.
mi
from
Lakeland, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Cancer Institute of Florida, PA - Orlando
mi
from
Orlando, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Cancer Institute of Florida, PA - Orlando
mi
from
Orlando, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Gulfcoast Oncology Associates
mi
from
St. Petersburg, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Gulfcoast Oncology Associates
mi
from
St. Petersburg, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Baptist Hospital East
mi
from
Louisville, KY
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Baptist Hospital East
mi
from
Louisville, KY
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Central Maine Medical Center
mi
from
Lewiston, ME
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Central Maine Medical Center
mi
from
Lewiston, ME
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
St. Louis Cancer and Breast Institute
mi
from
Saint Louis, MO
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
St. Louis Cancer and Breast Institute
mi
from
Saint Louis, MO
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
University of Nebrasaka Medical Center
mi
from
Omaha, NE
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Oncology Hematology Care
mi
from
Cincinnati, OH
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Oncology Hematology Care
mi
from
Cincinnati, OH
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Virginia Cancer Institute
mi
from
Richmond, VA
Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
A Phase II Trial of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Sunitinib or Bevacizumab
Status: Archived
Updated: 1/1/1970
Virginia Cancer Institute
mi
from
Richmond, VA
Phase I, Combining Oral Topotecan With Oral Pazopanib
A Phase I Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in Combination With Pazopanib in Subjects With Advanced Solid Tumors
Status: Archived
GSK Investigational Site
mi
from
Philadelphia, PA
Phase I, Combining Oral Topotecan With Oral Pazopanib
A Phase I Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Two Schedules of Oral Topotecan in Combination With Pazopanib in Subjects With Advanced Solid Tumors
Status: Archived
Updated: 1/1/1970
GSK Investigational Site
mi
from
Philadelphia, PA
Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869
A Pharmacokinetic Study to Evaluate the Effect of Food on the Oral Bioavailability and Effect of Diurnal Variation on the Pharmacokinetics of ABT-869
Status: Archived
Clinical Research Facility
mi
from
Detroit, MI
Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869
A Pharmacokinetic Study to Evaluate the Effect of Food on the Oral Bioavailability and Effect of Diurnal Variation on the Pharmacokinetics of ABT-869
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Detroit, MI
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
A Phase I/II Trial of Radiation, Avastin and Tarceva for Resectable or Locally Advanced Pancreatic Adenocarcinoma
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma
A Phase I/II Trial of Radiation, Avastin and Tarceva for Resectable or Locally Advanced Pancreatic Adenocarcinoma
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Clearview Cancer Institute
mi
from
Huntsville, AL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Clearview Cancer Institute
mi
from
Huntsville, AL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Florida Cancer Specialists
mi
from
Fort Myers, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Florida Cancer Specialists
mi
from
Fort Myers, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Integrated Community Oncology Network
mi
from
Jacksonville Beach, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Integrated Community Oncology Network
mi
from
Jacksonville Beach, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Watson Clinic Center for Research, Inc.
mi
from
Lakeland, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Watson Clinic Center for Research, Inc.
mi
from
Lakeland, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Cancer Institute of Florida, PA - Orlando
mi
from
Orlando, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Cancer Institute of Florida, PA - Orlando
mi
from
Orlando, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Northeast Georgia Heart Center, PC
mi
from
Gainesville, FL
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
WellStar Health System
mi
from
Marietta, GA
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
WellStar Health System
mi
from
Marietta, GA
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Oncology Hematology Associates of SW Indiana
mi
from
Evansville, IN
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Oncology Hematology Associates of SW Indiana
mi
from
Evansville, IN
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Consultants in Blood Disorders and Cancer
mi
from
Louisville, KY
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Consultants in Blood Disorders and Cancer
mi
from
Louisville, KY
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Baton Rouge General Medical Center
mi
from
Baton Rouge, LA
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Baton Rouge General Medical Center
mi
from
Baton Rouge, LA
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
CCOP - Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Jackson Oncology Associates
mi
from
Jackson, MS
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Jackson Oncology Associates
mi
from
Jackson, MS
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Nebraska Methodist Hospital
mi
from
Omaha, NE
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Nebraska Methodist Hospital
mi
from
Omaha, NE
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Hematology Oncology Associates of Northern NJ
mi
from
Morristown, NJ
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Oncology Hematology Care
mi
from
Cincinnati, OH
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Oncology Hematology Care
mi
from
Cincinnati, OH
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Spartanburg Regional Health Service District
mi
from
Spartanburg, SC
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Spartanburg Regional Health Service District
mi
from
Spartanburg, SC
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
A Phase II Study of Chemotherapy Treatment Based on Molecular Profiling Diagnosis for Patients With Carcinoma of Unknown Primary Site
Status: Archived
Updated: 1/1/1970
Tennessee Oncology, PLLC
mi
from
Nashville, TN